Optimum Investment Advisors Sells 720 Shares of Aetna Inc (AET)

Optimum Investment Advisors decreased its holdings in shares of Aetna Inc (NYSE:AET) by 3.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 20,829 shares of the company’s stock after selling 720 shares during the period. Aetna makes up 1.1% of Optimum Investment Advisors’ holdings, making the stock its 17th largest position. Optimum Investment Advisors’ holdings in Aetna were worth $3,312,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of AET. Bruderman Asset Management LLC bought a new stake in shares of Aetna in the 2nd quarter valued at $106,000. Lloyds Banking Group plc bought a new stake in shares of Aetna in the 3rd quarter valued at $106,000. Moisand Fitzgerald Tamayo LLC bought a new stake in shares of Aetna in the 3rd quarter valued at $116,000. Westside Investment Management Inc. increased its position in shares of Aetna by 53.5% in the 2nd quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock valued at $177,000 after buying an additional 400 shares in the last quarter. Finally, Phocas Financial Corp. bought a new stake in shares of Aetna in the 2nd quarter valued at $182,000. Institutional investors own 88.01% of the company’s stock.

In other news, President Karen S. Lynch sold 15,271 shares of the stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now directly owns 64,261 shares in the company, valued at approximately $10,404,498.51. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.90% of the company’s stock.

Aetna Inc (NYSE:AET) opened at $178.49 on Friday. Aetna Inc has a one year low of $116.04 and a one year high of $192.37. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 0.53. The company has a market cap of $58,420.72, a PE ratio of 17.54, a PEG ratio of 1.63 and a beta of 0.61.

Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, topping the Zacks’ consensus estimate of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The company had revenue of $14.99 billion during the quarter, compared to the consensus estimate of $15.12 billion. During the same period in the prior year, the business posted $2.07 EPS. The company’s quarterly revenue was down 5.0% on a year-over-year basis. research analysts anticipate that Aetna Inc will post 9.78 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.12%. Aetna’s dividend payout ratio is 37.04%.

A number of analysts recently commented on the stock. Credit Suisse Group restated a “neutral” rating and issued a $195.00 price objective (up previously from $174.00) on shares of Aetna in a research report on Wednesday, December 6th. Argus cut shares of Aetna from a “buy” rating to a “hold” rating and set a $185.00 price objective for the company. in a research report on Wednesday, December 6th. Wells Fargo & Company restated an “outperform” rating and issued a $208.00 price objective (up previously from $200.00) on shares of Aetna in a research report on Monday, December 4th. Piper Jaffray Companies restated a “hold” rating and issued a $187.00 price objective on shares of Aetna in a research report on Friday, November 3rd. Finally, Raymond James Financial upgraded shares of Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price objective for the company in a research report on Friday, November 3rd. Twelve research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $175.19.

COPYRIGHT VIOLATION NOTICE: This news story was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another domain, it was stolen and republished in violation of US and international trademark & copyright law. The original version of this news story can be accessed at https://www.dispatchtribunal.com/2017/12/15/optimum-investment-advisors-sells-720-shares-of-aetna-inc-aet.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply